CardioVascular BioTherapeutics (fka CVBT)

[johnnymcgriffin347]

InvestorsHub and Zhittya Genesis Medicine

I just got this email from InvestorsHub:

Breakthrough Medical Discovery



Can Therapeutic Angiogenesis Treat Heart Disease, Strokes, Peripheral Artery Disease, Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Depression and more?



Free Informational-Only Webinar Presentation on Therapeutic Angiogenesis : The medical science and the clinical evidence. There is no product or service for sale, since our pharmaceutical has not yet been approved by the US FDA.

Over 50% of all deaths in adults worldwide are the result of insufficient blood flow due to some form of obstruction. Over 75 human diseases result from a lack of blood flow to a tissue or organ, including heart disease, the number one cause of death in the world. Stroke also results from a lack of blood flow and is the number three killer in the world.

Recent medical discoveries from imaging blood flow in the brain are showing that “vascular disruption” is an initiating cause of Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis, chronic depression and other neurodegenerative diseases. Many of these diseases are diseases of aging and as you age, you have less blood flow in your brain. If your memory neurons in your brain are not receiving sufficient blood to provide them oxygen, nutrients and the removal of waste products for their proper functioning then they do not perform properly. Many medical researchers believe that the lack of blood flow in the brain is the cause of Alzheimer’s disease.

Therapeutic Angiogenesis is the medical therapy of utilizing a bio-manufactured human molecule that triggers “angiogenesis”. Angiogenesis is the biological process of growing new blood vessels. Your body does this when you scrape your elbow. Your body makes the very same molecule we are utilizing in our clinical trials. Our drug is a growth factor which signals your body to regenerate (repair) the wounded area, including new skin, new nerves, new sweat glands and new blood vessels; this molecule is how you have healed yourself thousands of times in your life.

Here is a link to an ABC Nightly News Broadcast on a US FDA cleared clinical trial, conducted at the University of Cincinnati, where our drug grew new blood vessels in the heart of a desperately sick person. Watch how our drug grew new blood vessels in a diseased heart. Link:

We have started clinical trials for (1) heart disease, (2) healing diabetic foot ulcers, (3) Parkinson’s disease, (4) stroke recovery, (5) Alzheimer’s disease, (6) Peripheral Artery disease, (7) Amyotrophic Lateral Sclerosis (ALS), (8) Multiple Sclerosis, (9) chronic depression and more. This might sound like a lot of trials but the underlying cause of these diseases is the same: a lack of blood flow to a tissue or organ; our drug can address that underlying cause by growing new blood vessels.

Over the last 20 years, we have expended hundreds of millions of dollars advancing this medicine. We want you to be aware of just how large we believe this medical breakthrough is and how Therapeutic Angiogenesis has the potential to give us all an additional 10 to 30 years of quality life.

The free Webinar will be broadcasted Saturday, August 29 at 9:00 AM Pacific (12:00 noon Eastern and 6:00 PM CET-Central European Time).

The topic is: Therapeutic Angiogenesis: What is it and How it has the Potential to Treat Diseases Which Kill Over 50% of All Adults Worldwide.

For additional information and to register for this free, information-only Webinar go to:

Link: zgmzoom.com

Zhittya Genesis Medicine Inc., is a private company which is developing biopharmaceuticals to treat the cause of death for over 50% of all adults. For more information go to our website: zgm.care